Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Project: Other project

StatusFinished
Effective start/end date3/6/173/5/19

Funding

  • Inventiv Health Clinical: $10,775.15